Government-Owned Inventions; Availability for Licensing and Cooperative Research and Development Agreements (CRADAs), 11671-11672 [E6-3268]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 45 / Wednesday, March 8, 2006 / Notices
Dated: March 2, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–3261 Filed 3–7–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Government-Owned Inventions;
Availability for Licensing and
Cooperative Research and
Development Agreements (CRADAs)
AGENCY: Centers for Disease Control and
Prevention Technology Transfer Office;
Department of Health and Human
Services.
ACTION:
Notice.
SUMMARY: The invention named in this
notice is owned by agencies of the
United States Government and is
available for licensing in the United
States (U.S.) in accordance with 35
U.S.C. 207, and is available for
cooperative research and development
agreements (CRADAs) in accordance
with 15 U.S.C. 3710a, to achieve
expeditious commercialization of
results of federally funded research and
development. A provisional patent
application has been filed. A Patent
Cooperation Treaty (PCT) application
and national stage foreign patent
applications claiming priority to the
Patent Cooperation Treaty (PCT)
application are expected to be filed
within the appropriate deadlines to
extend market coverage for U.S.
companies and may also be available for
licensing.
Licensing and CRADA
information, and information related to
the technology listed below, may be
obtained by writing to Suzanne Seavello
Shope, J.D., Technology Licensing and
Marketing Scientist, Technology
Transfer Office, Centers for Disease
Control and Prevention (CDC), Mailstop
K–79, 4770 Buford Highway, Atlanta,
GA 30341, telephone (770)488–8613;
facsimile (770)488–8615; or e-mail
sshope@cdc.gov. A signed Confidential
Disclosure Agreement (available under
Forms at https://www.cdc.gov/tto) will be
required to receive copies of
unpublished patent applications and
other information.
erjones on PROD1PC68 with NOTICES
ADDRESSES:
VerDate Aug<31>2005
15:53 Mar 07, 2006
Jkt 208001
Diagnostics
Immunoassay for Diagnosis of
Orthopoxvirus Infection
A CDC-developed immunoassay may
be used for the diagnosis of infection
with Orthopoxviruses (e.g. Monkeypox,
Variola) by detection of acute phase
immune responses that correlate to
recent infection. With recent recognition
of Orthopox viruses as emerging
infectious agents with zoonotic
transmission capabilities as well as
select agents for bioterrorism, assays for
the detection or diagnosis of infections
are sought. This assay provides a rapid
and simple method for detection of
infection with these viruses related to
zoonotic transmission or bioterrorism
events involving such viruses.
Use of the assay produced high levels
of sensitivity during the 2003
Monkeypox outbreak in North America
when compared to PCR.
Commercialization of the ELISA test
may provide a standard screening tool
for diagnosis of Orthopoxvirus as well
as a surveillance tool for exposure.
The immunoassay may also be useful
at the state level for BT surveillance
including an opportunity for use in
reference labs. Reagents used in the
assay are available through CDC
laboratories and for commercial
development of the assay. Further
refinement of the assay may result in the
development of additional reagents for
incorporation into the assay.
Inventors: Kevin L. Karem, Inger K.
Damon and Joanne L. Patton.
CDC Ref. #: I–014–04.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E6–3267 Filed 3–7–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Government-Owned Inventions;
Availability for Licensing and
Cooperative Research and
Development Agreements (CRADAs)
AGENCY: Centers for Disease Control and
Prevention, Technology Transfer Office,
Department of Health and Human
Services.
ACTION: Notice.
SUMMARY: The invention named in this
notice is owned by agencies of the
United States Government and is
available for licensing in the United
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
11671
States (U.S.) in accordance with 35
U.S.C. 207, and is available for
cooperative research and development
agreements (CRADAs) in accordance
with 15 U.S.C. 3710a, to achieve
expeditious commercialization of
results of federally funded research and
development. A provisional patent
application has been filed. In addition,
the invention is protected by copyright
registration. A Patent Cooperation
Treaty (PCT) application and national
stage foreign patent applications
claiming priority to the Patent
Cooperation Treaty (PCT) application
are expected to be filed within the
appropriate deadlines to extend market
coverage for U.S. companies and may
also be available for licensing.
ADDRESSES: Licensing and CRADA
information, and information related to
the technology listed below, may be
obtained by writing to Suzanne Seavello
Shope, J.D., Technology Licensing and
Marketing Scientist, Technology
Transfer Office, Centers for Disease
Control and Prevention (CDC), Mailstop
K–79, 4770 Buford Highway, Atlanta,
GA 30341, telephone (770)488–8613;
facsimile (770)488–8615; or e-mail
sshope@cdc.gov. A signed Confidential
Disclosure Agreement (available under
Forms at www.cdc.gov/tto) will be
required to receive copies of
unpublished patent applications and
other information.
Software
Computer Software for Automating
Permeation Testing Data Analysis
Data analysis for chemical protective
clothing (CPC) permeation testing
involves a number of equations and
experimental factors. Experimenter bias
and possible calculation errors are
critical issues when determining
permeation parameters. In order to
compare results among different
laboratories and manufacturers, the
normalized breakthrough time is
required since it is not dependent on the
detection limits of the analytical system.
However, calculating the normalized
breakthrough time requires the use of
polynomial curve fitting, polynomial
derivatives, and quadratic equations.
Solving these equations, without a
computer program, would be very
difficult. Therefore, a unique computer
program using Microsoft Visual C++,
referred to as ‘‘Permeation Calculator’’,
has been developed at the National
Institute for Occupational Safety and
Health/National Personal Protective
Technology Laboratory (NIOSH/NPPTL)
to calculate the permeation parameters.
The program imports data and then
calculates the permeation parameters;
E:\FR\FM\08MRN1.SGM
08MRN1
11672
Federal Register / Vol. 71, No. 45 / Wednesday, March 8, 2006 / Notices
including breakthrough detection time,
ASTM normalized breakthrough time,
European normalized breakthrough
time, and steady-state permeation rate.
The calculation of these parameters is
based on a series of strategies,
approaches, and algorithms. At the end,
the program displays all the permeation
parameters as a report file that can be
saved as a Microsoft Excel file or a text
file. The program reduces the time spent
on data analysis from hours to seconds.
Inventors: Pengfei Gao and Beth
Tomasovic.
CDC Ref.#: I–011–05.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E6–3268 Filed 3–7–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Child Care Case-Level Report.
OMB No.: 0970–0167.
Description: Section 658K of the Child
Care and Development Block Grant Act
of 1990 ( Pub. L. 101–508, 42 U.S.C.
9858) requires that States and
Territories submit monthly case-level
data on the children and families
receiving direct services under the Child
Care and Development Fund. The
implementing regulations for the
statutorily required reporting are at 45
CFR 98.70. Case-level reports, submitted
quarterly or monthly (at grantee option)
include monthly sample or full
population case-level data. The data
elements to be included in these reports
are represented in the ACF–801.
Disaggregate data is used to determine
program and participant characteristics
as well as costs and levels of child care
services provided. This provides ACF
with the information necessary to make
reports to Congress, address national
child care needs, offer technical
assistance to grantees, meet performance
measures, and conduct research.
Consistent with the statute and
regulations, ACF requests extension of
the ACF–801.
Respondents: States, the District of
Columbia, and Territories including
Puerto Rico, Guam, the Virgin Islands,
American Samoa, and the Northern
Marianna Islands.
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
ACF–801 ..........................................................................................................
56
4
20
4,480
erjones on PROD1PC68 with NOTICES
Estimated Total Annual Burden
Hours: 4,480.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. E-mail:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Attn: Desk Officer for
ACF, E-mail address:
Katherine_T._Astrich.eop.gov.
Dated: February 2, 2006.
Robert Sargis,
Reports Clearance, Officer.
[FR Doc. 06–2167 Filed 3–7–06; 8:45 am]
BILLING CODE 4184–01–M
VerDate Aug<31>2005
15:53 Mar 07, 2006
Jkt 208001
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[USCG–2006–24052]
Propeller Strike Injury Avoidance
Workshop
Coast Guard, DHS.
Notice of meeting.
AGENCY:
ACTION:
SUMMARY: The U.S. Coast Guard Office
of Boating Safety, at the
recommendation of the National Boating
Safety Advisory Council (NBSAC) is
convening a Propeller Strike Injury
Avoidance Workshop to address
propeller strike avoidance issues. The
workshop will be open to the public.
DATES: The workshop will be held on
Tuesday, March 21, 2006, from 8:30
a.m. to 5 p.m. and Wednesday, March
22, 2006, from 8 a.m. to 2:30 p.m. The
workshop may close early if all business
is finished.
ADDRESSES: The workshop will be held
at the Crowne Plaza Hotel, 1480 Crystal
Drive, Arlington, VA. This notice is
available on the Internet at https://
dms.dot.gov and at https://
uscgboating.org.
FOR FURTHER INFORMATION CONTACT:
Daniel McCormick, Project Manager,
Office of Boating Safety, U.S. Coast
Guard telephone 202–267–6894, fax
202–267–4285. If you have questions on
PO 00000
Frm 00100
Fmt 4703
Sfmt 4703
viewing material in the docket, call
Renee V. Wright, Program Manager,
Docket Operations, Department of
Transportation, telephone 202–493–
0402.
SUPPLEMENTARY INFORMATION: The
Commandant of the U.S. Coast Guard is
responsible for carrying out the National
Recreational Boating Safety Program.
Recreational boaters, swimmers, and
divers are at risk from recreational boats
as a result of incidents causing impact
with propellers, lower units and
appendages. The Coast Guard is engaged
with industry, other government
organizations, and the public to raise
the level of public awareness regarding
this safety risk, encourage technological
advancement to lower the level of risk,
and consider possible appropriate
regulatory action. Although significant
progress has been made, the Coast
Guard intends to continue its efforts to
foster active efforts to eliminate
propeller related injury as a significant
risk to the public.
The workshop will include a panel
discussion of educational,
technological, and any other issues
relevant to the mitigation/elimination of
propeller injury hazards. Panel members
have been selected based on the unique
perspective and benefit their input
would add to the discussions. We plan
to prepare minutes of the discussions
and distribute them to everyone who
registers attendance at the meeting by
E:\FR\FM\08MRN1.SGM
08MRN1
]]>Agencies
[Federal Register Volume 71, Number 45 (Wednesday, March 8, 2006)]
[Notices]
[Pages 11671-11672]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-3268]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Government-Owned Inventions; Availability for Licensing and
Cooperative Research and Development Agreements (CRADAs)
AGENCY: Centers for Disease Control and Prevention, Technology Transfer
Office, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The invention named in this notice is owned by agencies of the
United States Government and is available for licensing in the United
States (U.S.) in accordance with 35 U.S.C. 207, and is available for
cooperative research and development agreements (CRADAs) in accordance
with 15 U.S.C. 3710a, to achieve expeditious commercialization of
results of federally funded research and development. A provisional
patent application has been filed. In addition, the invention is
protected by copyright registration. A Patent Cooperation Treaty (PCT)
application and national stage foreign patent applications claiming
priority to the Patent Cooperation Treaty (PCT) application are
expected to be filed within the appropriate deadlines to extend market
coverage for U.S. companies and may also be available for licensing.
ADDRESSES: Licensing and CRADA information, and information related to
the technology listed below, may be obtained by writing to Suzanne
Seavello Shope, J.D., Technology Licensing and Marketing Scientist,
Technology Transfer Office, Centers for Disease Control and Prevention
(CDC), Mailstop K-79, 4770 Buford Highway, Atlanta, GA 30341, telephone
(770)488-8613; facsimile (770)488-8615; or e-mail sshope@cdc.gov. A
signed Confidential Disclosure Agreement (available under Forms at
www.cdc.gov/tto) will be required to receive copies of unpublished
patent applications and other information.
Software
Computer Software for Automating Permeation Testing Data Analysis
Data analysis for chemical protective clothing (CPC) permeation
testing involves a number of equations and experimental factors.
Experimenter bias and possible calculation errors are critical issues
when determining permeation parameters. In order to compare results
among different laboratories and manufacturers, the normalized
breakthrough time is required since it is not dependent on the
detection limits of the analytical system. However, calculating the
normalized breakthrough time requires the use of polynomial curve
fitting, polynomial derivatives, and quadratic equations. Solving these
equations, without a computer program, would be very difficult.
Therefore, a unique computer program using Microsoft Visual C++,
referred to as ``Permeation Calculator'', has been developed at the
National Institute for Occupational Safety and Health/National Personal
Protective Technology Laboratory (NIOSH/NPPTL) to calculate the
permeation parameters. The program imports data and then calculates the
permeation parameters;
[[Page 11672]]
including breakthrough detection time, ASTM normalized breakthrough
time, European normalized breakthrough time, and steady-state
permeation rate. The calculation of these parameters is based on a
series of strategies, approaches, and algorithms. At the end, the
program displays all the permeation parameters as a report file that
can be saved as a Microsoft Excel file or a text file. The program
reduces the time spent on data analysis from hours to seconds.
Inventors: Pengfei Gao and Beth Tomasovic.
CDC Ref.#: I-011-05.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention.
[FR Doc. E6-3268 Filed 3-7-06; 8:45 am]
BILLING CODE 4163-18-P
